# Safety and Efficacy Study of the First Domestically Produced FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter Therapy for Rapid Arrhythmia With Tissue Temperature Measurement Function

> **NCT07032948** · NA · NOT_YET_RECRUITING · sponsor: **Shanghai MicroPort EP MedTech Co., Ltd.** · enrollment: 300 (estimated)

## Conditions studied

- Rapid Arrhythmia
- Atrial Fibrillation (AF)
- Paroxysmal Supraventricular Tachycardia (PSVT)

## Interventions

- **DEVICE:** FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter、EasyStars™ High Density Mapping Catheter、Columbus™ 3D EP Navigation System

## Key facts

- **NCT ID:** NCT07032948
- **Lead sponsor:** Shanghai MicroPort EP MedTech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-31
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-08-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07032948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07032948, "Safety and Efficacy Study of the First Domestically Produced FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter Therapy for Rapid Arrhythmia With Tissue Temperature Measurement Function". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT07032948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*